Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion - PubMed (original) (raw)
. 2008 Jun 15;180(12):7898-906.
doi: 10.4049/jimmunol.180.12.7898.
Thomas Haudebourg, Flora Coulon, Michèle Heslan, Fabienne Haspot, Nicolas Poirier, Romain Vuillefroy de Silly, Claire Usal, Helga Smit, Bernard Martinet, Pamela Thebault, Karine Renaudin, Bernard Vanhove
Affiliations
- PMID: 18523253
- DOI: 10.4049/jimmunol.180.12.7898
Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion
Anne-Sophie Dugast et al. J Immunol. 2008.
Abstract
The immune tolerance to rat kidney allografts induced by a perioperative treatment with anti-CD28 Abs is associated with a severe unresponsiveness of peripheral blood cells to donor Ags. In this model, we identified an accumulation in the blood of CD3(-)class II(-)CD11b(+)CD80/86(+) plastic-adherent cells that additionally expressed CD172a as well as other myeloid markers. These cells were able to inhibit proliferation, but not activation, of effector T cells and to induce apoptosis in a contact-dependent manner. Their suppressive action was found to be under the control of inducible NO synthase, an enzyme also up-regulated in tolerated allografts. Based on these features, these cells can be defined as myeloid-derived suppressor cells (MDSC). Interestingly, CD4(+)CD25(high)FoxP3(+) regulatory T cells were insensitive in vitro to MDSC-mediated suppression. Although the adoptive transfer of MDSC failed to induce kidney allograft tolerance in recently transplanted recipients, the maintenance of tolerance after administration of anti-CD28 Abs was found to be dependent on the action of inducible NO synthase. These results suggest that increased numbers of MDSC can inhibit alloreactive T cell proliferation in vivo and that these cells may participate in the NO-dependent maintenance phase of tolerance.
Similar articles
- Exogenous interleukin-33 targets myeloid-derived suppressor cells and generates periphery-induced Foxp3⁺ regulatory T cells in skin-transplanted mice.
Gajardo T, Morales RA, Campos-Mora M, Campos-Acuña J, Pino-Lagos K. Gajardo T, et al. Immunology. 2015 Sep;146(1):81-8. doi: 10.1111/imm.12483. Epub 2015 Jun 19. Immunology. 2015. PMID: 25988395 Free PMC article. - IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.
Turnquist HR, Zhao Z, Rosborough BR, Liu Q, Castellaneta A, Isse K, Wang Z, Lang M, Stolz DB, Zheng XX, Demetris AJ, Liew FY, Wood KJ, Thomson AW. Turnquist HR, et al. J Immunol. 2011 Nov 1;187(9):4598-610. doi: 10.4049/jimmunol.1100519. Epub 2011 Sep 26. J Immunol. 2011. PMID: 21949025 Free PMC article. - SSC(high)CD11b(high)Ly-6C(high)Ly-6G(low) myeloid cells curtail CD4 T cell response by inducible nitric oxide synthase in murine hepatitis.
Zhu K, Zhang N, Guo N, Yang J, Wang J, Yang C, Yang C, Zhu L, Xu C, Deng Q, Zhu R, Wang H, Chen X, Shi Y, Li Y, Leng Q. Zhu K, et al. Int J Biochem Cell Biol. 2014 Sep;54:89-97. doi: 10.1016/j.biocel.2014.07.005. Epub 2014 Jul 15. Int J Biochem Cell Biol. 2014. PMID: 25035167 - Myeloid-derived suppressor cells participate in preventing graft rejection.
Wang Y, Gu X, Xiang J, Chen Z. Wang Y, et al. Clin Dev Immunol. 2012;2012:731486. doi: 10.1155/2012/731486. Epub 2012 Mar 15. Clin Dev Immunol. 2012. PMID: 22481970 Free PMC article. Review. - Myeloid-derived suppressor cells: linking inflammation and cancer.
Ostrand-Rosenberg S, Sinha P. Ostrand-Rosenberg S, et al. J Immunol. 2009 Apr 15;182(8):4499-506. doi: 10.4049/jimmunol.0802740. J Immunol. 2009. PMID: 19342621 Free PMC article. Review.
Cited by
- Update on lung transplantation: programmes, patients and prospects.
Kotsimbos T, Williams TJ, Anderson GP. Kotsimbos T, et al. Eur Respir Rev. 2012 Dec 1;21(126):271-305. doi: 10.1183/09059180.00006312. Eur Respir Rev. 2012. PMID: 23204117 Free PMC article. Review. No abstract available. - Dual roles of myeloid-derived suppressor cells in various diseases: a review.
Nepal MR, Shah S, Kang KT. Nepal MR, et al. Arch Pharm Res. 2024 Jul;47(7):597-616. doi: 10.1007/s12272-024-01504-2. Epub 2024 Jul 15. Arch Pharm Res. 2024. PMID: 39008186 Review. - Current status of alloimmunity.
Borges TJ, Murakami N, Riella LV. Borges TJ, et al. Curr Opin Nephrol Hypertens. 2016 Nov;25(6):556-562. doi: 10.1097/MNH.0000000000000267. Curr Opin Nephrol Hypertens. 2016. PMID: 27584931 Free PMC article. Review. - Inducible nitric oxide synthase-expressing myeloid-derived suppressor cells regulated by interleukin 35 contribute to the pathogenesis of psoriasis.
Zhang J, Zhang Y, Yang Z, Cheng D, Zhang H, Wei L, Liu C, Yan F, Li C, Dong G, Wang C, Shi D, Xiong H. Zhang J, et al. Front Immunol. 2023 Mar 9;14:1091541. doi: 10.3389/fimmu.2023.1091541. eCollection 2023. Front Immunol. 2023. PMID: 36969174 Free PMC article. - Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy.
Zhang W, Li J, Qi G, Tu G, Yang C, Xu M. Zhang W, et al. J Transl Med. 2018 Jan 29;16(1):19. doi: 10.1186/s12967-018-1395-9. J Transl Med. 2018. PMID: 29378596 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials